Complications After Endosonography and Guided Bronchoscopy
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Completed
CT.gov ID
NCT04621344
Collaborator
(none)
701
1
16.3
42.9
Study Details
Study Description
Brief Summary
The present study aims to investigate prospectively and systematically the direct and indirect complications occurring within 30 days after guided-bronchoscopy and/or endosonography. The results of the study should reliably help clarify further incidence, pattern, risk factors, and outcomes for both immediate and late complications associated with these key diagnostic procedures.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
701 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
30-DAY MORBIDITY, MORTALITY AND UNPLANNED HOSPITAL ADMISSIONS AFTER GUIDED-BRONCHOSCOPY AND ENDOSONOGRAPHY
Actual Study Start Date
:
Oct 27, 2020
Actual Primary Completion Date
:
Feb 7, 2022
Actual Study Completion Date
:
Mar 8, 2022
Outcome Measures
Primary Outcome Measures
- Incidence of severe complications [30 days]
Secondary Outcome Measures
- Overall incidence of complications [30 days]
- Risk factors associated with severe complications [30 days]
- Rate of unplanned hospital admissions [30 days]
- Mortality [30 days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Age >18 years,
-
Indication to undergo bronchoscopy, endosonography, or both.
-
Signed informed consent
Exclusion Criteria:
-
Absolute contraindications to the bronchoscopic examination based on international guidelines [31].
-
Platelet count <50000
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Fondazione Policlinico Universitario A. Gemelli IRCCS | Roma | Lazio | Italy | 00168 |
Sponsors and Collaborators
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Investigators
- Principal Investigator: Rocco Trisolini, MD, Fondazione Policlinico Universitario A. Gemelli IRCS, Università Cattolica del Sacro Cuore
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ClinicalTrials.gov Identifier:
NCT04621344
Other Study ID Numbers:
- ST1
First Posted:
Nov 9, 2020
Last Update Posted:
Apr 14, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fondazione Policlinico Universitario Agostino Gemelli IRCCS